|
|
||||||||
Baker Medical Research Institute, Victoria, Australia
In the present study, we examined the effect of blockade of the brain stem renin-angiotensin system on renal sympathetic baroreflexes and chemoreflexes in conscious rabbits and examined the role of central catecholaminergic pathways in these responses. Eleven rabbits underwent preliminary surgical instrumentation and pretreatment with central 6-hydroxydopamine (6-OHDA, 500 µg/kg) or ascorbic acid 6 wk before the commencement of the experiments. Baroreflex curves were determined under conditions of normoxia and hypoxia (10% O2 + 3% CO2) before and after central administration of either Ringer solution, the ANG II receptor antagonist losartan (10 µg), or the angiotensin-converting enzyme inhibitor enalaprilat (500 ng) on separate days. Losartan increased the upper plateau and the range of the mean arterial pressure (MAP)-renal sympathetic nerve activity (RSNA) curve (79 and 78%, respectively) in intact rabbits, whereas this effect was not observed in 6-OHDA-pretreated rabbits. Hypoxia elicited an increase in resting RSNA (111% in intact rabbits and 74% in 6-OHDA-injected rabbits) and elevated the upper plateau of the RSNA-MAP curve in both groups (89% in intact rabbits and 114% in 6-OHDA-injected rabbits). During hypoxia, losartan and enalaprilat increased the RSNA upper plateau in intact rabbits but had no effect in 6-OHDA-pretreated rabbits. No effects on the MAP-heart rate baroreflex curves were observed. Thus the effect of losartan to increase RSNA, particularly during hypoxia and baroreceptor unloading, being abolished by central noradrenergic depletion suggests that the endogenous ANG II which normally causes an inhibition of renal sympathetic motoneurons is dependent on the integrity of central catecholaminergic pathways.
baroreceptor reflex; hypoxia; chemoreceptor reflex; losartan; angiotensin type 1 receptors; enalaprilat; blood pressure; fourth ventricular administration
This article has been cited by other articles:
![]() |
M. J. Sheriff, M. A. P. Fontes, S. Killinger, J. Horiuchi, and R. A. L. Dampney Blockade of AT1 receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R733 - R740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sanderford and V. S. Bishop Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1592 - H1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. O'Hagan, K. A. Skogg, and J. B. Stevenson AT1 receptor block does not affect arterial baroreflex during pregnancy in rabbits Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1996 - H2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sanderford and V. S. Bishop Angiotensin II acutely attenuates range of arterial baroreflex control of renal sympathetic nerve activity Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1804 - H1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ackermann and N. Azizi Increased central AT1-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1441 - R1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gaudet, S. J. Godwin, and G. A. Head Effects of central infusion of ANG II and losartan on the cardiac baroreflex in rabbits Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H558 - H566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, D.-N. Zhu, Z. Yu, J. Q. Wang, Z.-J. Sun, and T. Yao Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats J Appl Physiol, May 1, 2002; 92(5): 2153 - 2161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |